Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-05-01 IMVT / Immunovant, Inc. 4 Susman Robert Graham S - Sale D 27.17 -2,502
2026-05-01 PCVX / Vaxcyte, Inc. 4 Wassil Jim S - Sale D 56.831 -2,250
2026-05-01 FENC / Fennec Pharmaceuticals Inc. 4 Raykov Rosty S - Sale D 6.47 -10,781
2026-05-01 FENC / Fennec Pharmaceuticals Inc. 4 Raykov Rosty M - Exercise D 2.45 15,598
2026-04-30 FENC / Fennec Pharmaceuticals Inc. 4 Evans Terry L M - Exercise D 168
2026-04-30 FENC / Fennec Pharmaceuticals Inc. 4 Hackman Jeffrey S. M - Exercise D 1,159
2026-04-30 FENC / Fennec Pharmaceuticals Inc. 4 Andrade Robert M - Exercise D 1,703
2026-04-30 FENC / Fennec Pharmaceuticals Inc. 4 Cioffi Christiana Marie M - Exercise D 155
2026-04-30 FENC / Fennec Pharmaceuticals Inc. 4 Raykov Rosty M - Exercise D 2,778
2026-04-30 FENC / Fennec Pharmaceuticals Inc. 4 Sayad Pierre Sargis M - Exercise D 168
2026-04-29 KYMR / Kymera Therapeutics, Inc. 4 Mainolfi Nello S - Sale D 80.74 -17,005
2026-04-29 KYMR / Kymera Therapeutics, Inc. 4 Mainolfi Nello S - Sale D 81.70 -12,059
2026-04-29 KYMR / Kymera Therapeutics, Inc. 4 Mainolfi Nello S - Sale D 82.45 -936
2026-04-29 CMPX / Compass Therapeutics, Inc. 4/A Anderman Jonathan P - Purchase D 1.89 25,000
2026-04-29 CMPX / Compass Therapeutics, Inc. 4/A Lerner Neil P - Purchase D 1.89 15,000
2026-04-29 BCDA / BioCardia, Inc. 4 Altman Peter P - Purchase D 1.11 5,000
2026-04-29 VCEL / Vericel Corporation 4 MCLAUGHLIN KEVIN F M - Exercise D 3,200
2026-04-29 VCEL / Vericel Corporation 4 Wotton Paul K M - Exercise D 3,200
2026-04-29 VCEL / Vericel Corporation 4 ZERBE ROBERT L MD M - Exercise D 3,200
2026-04-29 VCEL / Vericel Corporation 4 WRIGHT LISA M - Exercise D 3,200
2026-04-29 KYMR / Kymera Therapeutics, Inc. 4 Mainolfi Nello M - Exercise D 2.08 30,000
2026-04-29 VCEL / Vericel Corporation 4 Hagen Heidi M - Exercise D 3,200
2026-04-29 VCEL / Vericel Corporation 4 Rubino Alan L M - Exercise D 3,200
2026-04-29 VIR / Vir Biotechnology, Inc. 4 De Backer Marianne J - Other D -233,532
2026-04-29 VIR / Vir Biotechnology, Inc. 4 De Backer Marianne J - Other I 233,532
2026-04-29 CMPX / Compass Therapeutics, Inc. 4 Anderman Jonathan A - Award D 1.89 25,000
2026-04-29 CMPX / Compass Therapeutics, Inc. 4 Lerner Neil A - Award D 1.89 15,000
2026-04-28 RLAY / Relay Therapeutics, Inc. 4 Bergstrom Donald A S - Sale D 14.79 -1,490
2026-04-28 RLAY / Relay Therapeutics, Inc. 4 Rahmer Peter S - Sale D 14.79 -753
2026-04-28 RLAY / Relay Therapeutics, Inc. 4 Catinazzo Thomas S - Sale D 14.79 -972
2026-04-28 GILD / Gilead Sciences, Inc. 4 O'Day Daniel Patrick S - Sale D 128.7877 -6,950
2026-04-28 GILD / Gilead Sciences, Inc. 4 O'Day Daniel Patrick S - Sale D 130.0111 -3,050
2026-04-28 PROK / ProKidney Corp. 4 Inversora Carso, S.A. de C.V. C - Conversion D 63,118,645
2026-04-27 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.23 -19,037
2026-04-27 RVMD / Revolution Medicines, Inc. 4 Mancini Anthony S - Sale D 134.335 -400
2026-04-27 RVMD / Revolution Medicines, Inc. 4 Mancini Anthony S - Sale D 131.6619 -1,671
2026-04-27 RVMD / Revolution Medicines, Inc. 4 Mancini Anthony S - Sale D 132.8768 -1,049
2026-04-27 TWST / Twist Bioscience Corporation 4 Starovasnik Melissa A. S - Sale D 61.83 -500
2026-04-27 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 8.46 14,707
2026-04-27 RVMD / Revolution Medicines, Inc. 4 Mancini Anthony M - Exercise D 33.62 3,120
2026-04-25 NVAX / Novavax, Inc. 4 Newton Charles W. M - Exercise D 9,520
2026-04-24 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.02 -19,060
2026-04-24 CGEN / Compugen Ltd. 4 Levine Zurit S - Sale D 3.20 -2,000
2026-04-24 CGEN / Compugen Ltd. 4 Ophir Eran S - Sale D 3.2001 -5,000
2026-04-24 TARS / Tarsus Pharmaceuticals, Inc. 4 PYOTT DAVID E I M - Exercise D 1,383
2026-04-24 CGEN / Compugen Ltd. 4 Levine Zurit M - Exercise D 1.15 2,000
2026-04-24 CGEN / Compugen Ltd. 4 Ophir Eran M - Exercise D 0.8292 5,000
2026-04-24 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 8.46 14,722
2026-04-23 IMVT / Immunovant, Inc. 4 Girao Tiago S - Sale D 29.62 -25,760
2026-04-23 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 13.74 -19,060
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)